CN Patent

CN111565761A — 荧光素和丁氧普鲁卡因组合物

Assigned to Peregrine Biotek · Expires 2020-08-21 · 6y expired

What this patent protects

本文描述了包含荧光素组分和丁氧普鲁卡因组分的组合物，以及这些组合物的相应用途。这些组合物具有改善的储存寿命，并且在储存12至18个月之后，荧光素组分和/或丁氧普鲁卡因组分最低限度降解。

USPTO Abstract

本文描述了包含荧光素组分和丁氧普鲁卡因组分的组合物，以及这些组合物的相应用途。这些组合物具有改善的储存寿命，并且在储存12至18个月之后，荧光素组分和/或丁氧普鲁卡因组分最低限度降解。

Drugs covered by this patent

benoxinate-hydrochloride (BENOXINATE HYDROCHLORIDE)

Patent Metadata

Patent number: CN111565761A
Jurisdiction: CN
Classification: —
Expires: 2020-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Peregrine Biotek
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.